Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy

Prostate Cancer and Prostatic Diseases

Volumn 16, Issue 1, 2013, Pages 28-34

  Cotignola, J ^a   Leonardi, D B ^a   Shahabi, A ^b   Acuna A D ^a   Stern, M C ^b   Navone, N ^c   Scorticati, C ^d   De Siervi, A ^a   Mazza, O ^d   Vazquez, E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

biochemical relapse; glutathione S transferase; GST; polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; PROSTATE ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARGENTINA; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FAMILY HISTORY; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GSTM1 GENE; GSTT1 GENE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84873729331     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2012.45     Document Type: Article

References (23)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Matos EL, Loria DI, Zengarini N, Fernandez MM, Guevel CG, Marconi E et al. Atlas de mortalidad por cáncer en Argentina 1997-2001. Asociación Argentina de Cáncer: Buenos Aires, 2003.
3. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-974. (Pubitemid 28445094)
4. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999; 17: 1499-1507. (Pubitemid 29220858)
5. Ramos CG, Roehl KA, Antenor JA, Humphrey PA, Catalona WJ. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol 2004; 172: 137-140. (Pubitemid 41615055)
6. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45: 51-88. (Pubitemid 40261798)
7. Di Paolo OA, Teitel CH, Nowell S, Coles BF, Kadlubar FF. Expression of cytochromes P450 and glutathione S-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetyl-coA-, PAPS-and ATP-dependent pathways. Int J Cancer 2005; 117: 8-13. (Pubitemid 41262754)
8. Mo Z, Gao Y, Cao Y, Gao F, Jian L. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate 2009; 69: 662-688.
9. Ntais C, Polycarpou A, Ioannidis JP. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2005; 14: 176-181. (Pubitemid 40165300)
10. Nock NL, Bock C, Neslund-Dudas C, Beebe-Dimmer J, Rundle A, Tang D et al. Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity. Cancer Causes Control 2009; 20: 1915-1926.
11. Agalliu I, Lin DW, Salinas CA, Feng Z, Stanford JL. Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. Prostate 2006; 66: 1535-1541. (Pubitemid 44465818)
12. Norskov MS, Frikke-Schmidt R, Bojesen SE, Nordestgaard BG, Loft S, Tybjaerg-Hansen A. Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population. Pharmacogenomics J 2011; 11: 292-299.
13. Acevedo C, Opazo JL, Huidobro C, Cabezas J, Iturrieta J, Quinones Sepulveda L. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. Prostate 2003; 57: 111-117. (Pubitemid 37204491)
14. Caceres DD, Iturrieta J, Acevedo C, Huidobro C, Varela N, Quinones L. Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions. Eur J Epidemiol 2005; 20: 79-88. (Pubitemid 40202687)
15. Avena S, Via M, Ziv E, Perez-Stable EJ, Gignoux CR, Dejean C et al. Heterogeneity in genetic admixture across different regions of Argentina. PLoS ONE 2012; 7: e34695.
16. Corcoran NM, Hovens CM, Metcalfe C, Hong MK, Pedersen J, Casey RG et al. Positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate-risk disease. BJU Int 2012; 110: 821-827.
17. Srivastava SK, Singhal SS, Hu X, Awasthi YC, Zimniak P, Singh SV. Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa. Arch Biochem Biophys 1999; 366: 89-94. (Pubitemid 29394233)
18. Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B et al. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Clin Cancer Res 2005; 11: 4037-4043. (Pubitemid 40791567)
19. Block G, Shaikh N, Jensen CD, Volberg V, Holland N. Serum vitamin C and other biomarkers differ by genotype of phase 2 enzyme genes GSTM1 and GSTT1. Am J Clin Nutr 2011; 94: 929-937.
20. To-Figueras J, Gene M, Gomez-Catalan J, Pique E, Borrego N, Carrasco JL et al. Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes Control 1999; 10: 65-70. (Pubitemid 29134754)
21. Ladero JM, Martinez C, Garcia-Martin E, Ropero P, Briceno O, Villegas A et al. Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: a study in the Spanish population. Eur J Cancer 2006; 42: 73-77. (Pubitemid 41814534)
22. Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P et al. Meta-and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol 2006; 164: 1027-1042. (Pubitemid 44851738)
23. Agudo A, Peluso M, Sala N, Capella G, Munnia A, Piro S et al. Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: findings from the EPIC-Spain cohort. Carcinogenesis 2009; 30: 968-976.